– CNBC
GeoVax Announces Expansion Of Next-Generation COVID-19 Vaccine Rights To Include Omicron Variants And Use Against Orthopoxviruses
Expanded Rights Include Development of GEO-CM04S1 Against Mpox (Monkeypox) and Smallpox
ATLANTA, GA, April 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology